Evidence Hub

Pathophysiology of CLD: Oxidative Stress and Antioxidant Mechanisms that may Limit its Progression

Theodosis-Nobelos P, Papagiouvanni I, Protopapas AA, Papagiouvannis G

Endocrine, metabolic & immune disorders drug targets, 2026

Abstract

INTRODUCTION: Chronic liver disease (CLD) represents a progressive condition culminating in fibrosis and, ultimately, cirrhosis or hepatocellular carcinoma. A growing body of evidence implicates oxidative and nitrosative stress as key mediators in the pathogenesis of CLD.

OBJECTIVE: This review aims to summarize the role of oxidative stress in CLD progression and to highlight therapeutic strategies targeting redox imbalance and related signaling pathways.

METHODS: Relevant literature from preclinical and clinical studies was reviewed, with emphasis on mechanisms of oxidative and nitrosative stress, signaling pathways involved in fibrogenesis, and emerging therapeutic interventions targeting redox imbalance and the gut-liver axis.

RESULTS AND DISCUSSION: Reactive oxygen and nitrogen species contribute to hepatocyte damage, hepatic stellate cell activation, and extracellular matrix accumulation. Mitochondrial dysfunction, endoplasmic reticulum stress, and disrupted redox homeostasis induce tissue injury and fibrogenesis. Various signaling pathways, including Nrf2/Keap1, AMPK/SIRT1, JNK, PI3K/Akt/mTOR, and TGF-β/SMAD, serve as critical links between oxidative imbalance and fibrotic progression. The antifibrotic potential of antioxidants such as vitamin E, lipoic acid, berberine, and polyphenolic compounds is increasingly validated in preclinical and clinical studies. Additionally, modulation of NOX enzymes and support of endogenous defenses offer promising therapeutic avenues.…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free